SIMCERE PHARMA plans to repurchase shares
I'm PortAI, I can summarize articles.
SIMCERE PHARMA announced plans to repurchase up to 247 million shares, accounting for 10% of the issued shares. The board of directors decided to exercise the repurchase authorization on August 21, 2025, planning to repurchase in the open market for a total amount not exceeding 500 million RMB. The board stated that this move reflects confidence in the company's business prospects and will create value for shareholders, while the company has sufficient financial resources to maintain a sound financial condition
Log in to access the full 0 words article for free
Due to copyright restrictions, please log in to view.
Thank you for supporting legitimate content.
Source: Zhitong The copyright of this article belongs to the original author/organization.
The views expressed herein are solely those of the author and do not reflect the stance of the platform. The content is intended for investment reference purposes only and shall not be considered as investment advice. Please contact us if you have any questions or suggestions regarding the content services provided by the platform.
Post your comment
No Comments